Sher-i-Kashmir Institute of Medical Sciences
Question
Asked 27 December 2014
What is the mechanism of inflammation or edema caused by carageenan?
I want to understand how carageenan causes inflammation. Carageenan induced paw edema is a standard method to get the idea of anti inflammatory of different products. But I am not able to understand how inflammation is caused by carageenan. Which pathways get activated and what other factors which are involved. I want to understand the process of carageenan induced edema with time.
Most recent answer
Thank you sirine
Popular answers (1)
Bandung Institute of Technology
All Answers (10)
University of the Western Cape
Carrageenan works via the Bcl10, NF-κB, IκBα pathway to activate inflammation mediators. This pathway initially involves phosphorylation steps followed by nuclear translocation of phospho-NF-κB. This sets off transcription and translation of inflammatory biomarkers such as COX, NOS, IL-6 etc. Inflammation causes many effects. One of the effects is vasodilation of capillaries/blood vessels. Below the surface where carrageenan has been applied, inflammation thus cause dilation of the capillaries underneath the skin surface. Thus increased blood flow to the area. Manifest as swelling/redness of the affected area.
4 Recommendations
University of Sciences and Technology Houari Boumediene
many mediators can be involved in carrageenan induced inflammtion such as Kinins, histamin and the prostaglandine, and carrageenan is capable of releasing kinin- like sucstances from plasma
Ivogen
Carrageenan is a complex polysaccharide that binds to TLR4, activating Bcl10 and the NFKB pathway. It is used to induce inflammation for the evaluating agents that might have anti-inflammatory properties. See the attached reference for mechanistic study and the reference below for use in models of inflammation.
Duarte DB, Vasko MR, Fehrenbacher JC. (2012) Models of Inflammation: carrageenan air pouch. Current Protocols in Pharmacology, Chapter 5
1 Recommendation
Bharati Vidyapeeth Deemed University
The mechanism responsible for carrageenan-induced immune suppression is believed to be its selective cytopathic effect on macrophages. This property of carrageenan has led to its adoption as a tool for analysing the role of these cells in the induction and expression of immune reactivity. Systemic administration of earrageenan may, however, induce disseminated intravascular coagulation and inflict damage on both the liver and kidney. This is an important consideration in the interpretation of the effects of carrageenan in vivo and precludes its use as a clinical immune suppressant.
Independent Physician and Medical Researcher
I wonder if carrageenan might be related somehow to the Sannarelli-Shwartzman phenomenon?
Udayana University
Several previous studies that used carrageenan as an inflammatory irritant. The inflammatory mechanisms describes like this. First carrageenan stimulates release of TNF-α which further induces IL-1β and IL-6, then stimulates the production of cyclooxygenase (COX) products and induces other cytokines, IL-8 thus stimulating local production of symphatic amines. Thus cascade cytokine release precedes the release of cyclooxidase (COX) and sympathomimetic amine product (Necas and Bartosikova, 2013)
1 Recommendation
Université de Bretagne Occidentale
Hi,
In order to understand the inflammatory mechanisms caused by carrageenan you can check this paper : https://www.researchgate.net/publication/301550110_In_vitro_immunomodulatory_activity_and_in_vivo_anti-inflammatory_and_analgesic_potential_with_gastroprotective_effect_of_the_Mediterranean_red_alga_Laurencia_obtusa
Similar questions and discussions
Related Publications
PROSTAGLANDINS are released in inflammatory reactions in animals1 and in man2. The observation that non-steroidal anti-inflammatory agents inhibit prostaglandin synthesis in vitro3,4 and in vivo5, and that the comparative potency of these anti-inflammatory compounds is the same in vitro and in vivo as inhibitors of carrageenin-induced oedema6, sugg...
An acute non-immune inflammation model was used to compare the action of two non-steroidal anti-inflammatory drugs, flunixin meglumine and tolfenamic acid, on prostaglandin E2 (PGE2) synthesis in bovine inflammatory exudate. The tissue cage model used involves subcutaneous implantation of polypropylene cages and subsequent stimulation by carrageena...
The anti-inflammatory effect of low-intensity extremely high-frequency electromagnetic radiation (EHF EMR, 42.0 GHz, 0.1 mW/cm2) was compared with the action of the known anti-inflammatory drug sodium diclofenac and the antihistamine clemastine on acute inflammatory reaction in NMRI mice. The local inflammatory reaction was induced by intraplantar...